Detection of Silent Aspiration Events Utilizing pH/Impedance Probes in Hospitalized Patients

N/AWithdrawnNCT02720029

Vanderbilt University

Overview

Monitoring and quantification of reflux events in high risk critically ill inpatients and lower risk general medical/surgical inpatients, with comparison to relevant clinical variables.

The investigators will conduct a pilot prospective cohort study of the incidence of reflux of gastric contents into the esophagus and the correlation with clinically evident aspiration events. The investigators will demonstrate that an esophageal multichannel pH/impedance probe can be used safely and effectively in an inpatient population to monitor reflux of acidic and non-acidic contents into the esophagus. The investigators will determine the frequency and severity of reflux events in a 24 hour period in two hospitalized patient populations: general medicine patients on the wards and critically ill patients in the intensive care unit. The investigators will then examine the relationship between the documented reflux events and clinically apparent aspiration events. The incidence of these silent reflux events in hospitalized patients is currently unclear.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Conditions

Acid Aspiration Syndrome

Interventions

pH/impedance monitorDEVICE

Placement of pH/impedance monitor via the nasogastric route with monitoring for 24 hours, followed by removal.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age greater than 18 years 2. Admitted to medical-surgical floor or medical intensive care unit Exclusion Criteria: 1. Patients with contraindication to nasogastric tube placement (facial trauma, active epistaxis, abnormal nasopharyngeal or facial anatomy, esophageal stricture or injury, esophageal varices) 2. Patients requiring non-invasive positive pressure ventilation 3. Patients with uncontrolled vomiting 4. Patients with planned or anticipated airway or esophageal procedure within the 24-hour monitoring period 5. Patients not expected to survive for 24 hours or those receiving hospice/palliative care

Outcomes

Primary Outcomes

Number of reflux events

Summation of acid reflux events and non-acid reflux events over 24hr monitoring period measured by pH change and impedance change detected by the probe

Time frame: 24 hours

Secondary Outcomes

Clinically apparent aspiration events

Counting clinically apparent aspiration events by way of manual chart review

Time frame: Duration of hospitalization, on average 14 days

Combined aspiration event endpoint

Summation of clinically apparent aspiration events, new infiltrates on chest imaging, increase in oxygen requirements, or need for higher level of care due to respiratory decompensation - all components determined by manual chart review

Time frame: Duration of hospitalization, on average 14 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.